Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification

Clinical Cancer Research

Volumn 16, Issue 24, 2010, Pages 6083-6092

  Damato, Bertil ^a   Dopierala, Justyna A ^b   Coupland, Sarah E ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CELL STRUCTURE; CHILD; CHOROID MELANOMA; CHROMOSOME 3; CHROMOSOME 6P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; UVEA MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHOROID NEOPLASMS; CYTOGENETIC ANALYSIS; DNA PROBES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; LIGASE CHAIN REACTION; MALE; MELANOMA; MIDDLE AGED; YOUNG ADULT;

EID: 78650388057     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-2076     Document Type: Article

References (25)

1. Kujala E, Mäkitie T, Kivelä T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44: 4651-9.
2. Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009;127:989-98.
3. Damato B, Coupland SE. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond) 2009;23: 2152-60.
4. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma risk factors and influence on survival probability. Ophthalmology 2008;115:1778-85.
5. Finger PT. The 7th edition AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med 2009;133:1197-8.
6. Coupland SE, Vorum H, Mandal N, et al. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Invest Ophthalmol Vis Sci 2010;51:12-20.
7. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-9.
8. Angi M, Damato B, Kalirai H, Dodson A, Taktak A, Coupland SE. Immunohistochemical assessment of mitotic count in uveal melanoma. Acta Ophthalmol. Epub 2009 Nov 7.
9. Bhat P, Jakobiec FA, Folberg R. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas. Semin Ophthalmol 2009;24:166-71.
10. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-5.
11. White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 1998;83:354-9.
12. Onken MD, Worley LA, Harbour JW. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res 2008;14:3737-45.
13. Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK. Monosomy3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003;44:1008-11.
14. Onken MD, Worley LA, Tuscan MD, Harbour JW. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 2010;12:461-8.
15. Damato B, Coupland SE. Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol 2009;127:423-9.
16. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a seven-year clinical experience. Ophthalmology 2007; 114:1925-31.
17. Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology 2008;115:1598-607.
18. van Dijk MC, Rombout PD, Boots-Sprenger SH, et al. Multiplex ligation- dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 2005;14:9-16.
19. Damato B, Dopierala J, Klaasen A, van DM, Sibbring J, Coupland SE. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 2009;50: 3048-55.
20. Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE. Genetic heterogeneity in uveal melanomaassessed bymultiplex ligation-dependent probe amplification. Invest Ophthalmol Vis Sci 2010;51:4898-905.
21. Damato B. Treatment of primary intraocular melanoma. Expert Rev Anticancer Ther 2006;6:493-506.
22. vanDongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317.
23. Höglund M, Gisselsson D, Hansen GB, et al. Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution. Int J Cancer 2004;108: 57-65.
24. Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000;107:1443-9.
25. Callejo SA, Dopierala J, Coupland SE, Damato B. Sudden growth of a choroidal melanoma and MLPA findings suggesting late transformation to monosomy-3 type. Archives of Ophthalmology. In press 2010.